• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $SACH

    Sachem Capital Corp.

    Subscribe to $SACH
    $SACH
    Real Estate Investment Trusts
    Real Estate

    Sachem Capital Corp. operates as a real estate finance company. The company is involved in the originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located primarily in Connecticut. It offers loans to real estate investors to fund their acquisition, renovation, rehabilitation, development, and/or improvement of residential or commercial properties. The company has elected to be taxed as a real estate investment trust (REIT) and would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. Sachem Capital Corp. was founded in 2010 and is based in Branford, Connecticut.

    IPO Year: 2017

    Exchange: AMEX

    Website: sachemcapitalcorp.com

    Peers

    $NBSE
    $KRMD
    $SCYX
    $SSSS
    $RC

    Recent Analyst Ratings for Sachem Capital Corp.

    DatePrice TargetRatingAnalyst
    4/3/2025Buy → Neutral
    Ladenburg Thalmann
    11/15/2024Buy → Neutral
    Alliance Global Partners
    3/18/2024$4.50Buy
    Alliance Global Partners
    11/14/2022Mkt Perform
    JMP Securities
    4/28/2022$6.00Outperform
    Oppenheimer
    See more ratings